TBR203

N/A

Report date: 2024/08/26 10:53:02

First In Class

Base Information

Drug NameTBR203

Drug Alias NameTBR203TBR-203

ClassificationOther

Mechanisms of ActionT cell immunoglobulin and ITIM domains modulators

TargetsT cell immunoglobulin and ITIM domains

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTwinpig Biolab Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A